Our Latest News

News

Announcement Clinical evidence

First randomised trial finds AI-supported mammography screening is safe and almost halved radiologist workload

Press Release From Lancet Oncology: The AI in use is Transpara First randomised trial finds AI-supported mammography screening is safe

Scandinavian Perspective of AI in Breast Screening EUSOBI 2022 Summary and Video

The Scandinavian key leaders of AI in breast imaging presented their research at the ScreenPoint symposium at EUSOBI 2022

New publication European Radiology – Can artificial intelligence reduce the interval cancer rate in mammography screening?

A new retrospective study from Sweden published in European Radiology https://doi.org/10.1007/s00330-021-07686-3 showed that Transpara AI detected 19% of interval cancer

Study confirms findings of the Transpara™ by ScreenPoint Medical AI mammogram decision support system

LONDON (PRWEB) JANUARY 03, 2020 ScreenPoint Medical’s Scientists who developed the Transpara AI decision support system which helps radiologists to identify

Transpara™ AI software equals radiologists in study published in the Journal of the National Cancer Institute

Deep learning software Transpara is shown to be robust and reliable in the largest AI study with screening mammograms to

Reader study evaluating Transpara™ AI software for improving mammography interpretation published in Radiology

Radiologists significantly improved their cancer detection in mammography without increasing reading times when using Transpara™ software from ScreenPoint Medical, according to